HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lindberg, S. Articles by Tisell, L.-E. Search for Related Content PubMed PubMed Citation Articles by Lindberg, S. Articles by Tisell, L.-E.

Methodology and Dosimetry in Adrenal Medullary Imaging with Iodine-131 MIBG

Division of Nuclear Medicine, Department of Diagnostic Radiology
Department of Radiation Physics
Department of Surgery, University of Göteborg, Sweden

Correspondence: For reprints contact: Martha Fjälling, MD, Div. of Nuclear Medicine, Dept. of Diagnostic Radiology, Sahlgrenska sjukhuset, S-413 45 Göteborg, Sweden.

ABSTRACT

Iodine-131 MIBG scans were performed in 59 patients in order to localize intra- or extra-adrenal pheochromocytomas (pheos), or to visualize hyperplastic adrenal medulla. Images were obtained from the pelvis to the base of the skull on Days 1, 4, and 7 after tracer injection. The 15 patients with histopathologic confirmation of adrenal medullary disease had positive scans. In three of these, the pheos were visible only on images obtained on Day 7. One scan was false negative. After excluding patients with a predisposition to adrenal medullary disease, nine subjects (28%) without verification of pheo displayed adrenal uptake of the radionuclide. Late images produce a low rate of false-negative scans; the background activity diminishes and even small pheos can be detected. In order to increase the quality of late images, 40 MBq [¹³¹I] MIBG was used instead of 20 MBq. The dosimetric considerations are discussed.

This article has been cited by other articles:

				D Cecchin, F Lumachi, M C Marzola, G Opocher, C Scaroni, P Zucchetta, F Mantero, and F Bui A meta-iodobenzylguanidine scintigraphic scoring system increases accuracy in the diagnostic management of pheochromocytoma. Endocr. Relat. Cancer, June 1, 2006; 13(2): 525 - 533. [Abstract] [Full Text] [PDF]